The objective of the present study was to investigate the postprandial metabolism of two starches with contrasting rates of hydrolysis in vitro. Characterized using the Englyst method of in vitro starch classification, C*Set 06 598 contained predominantly rapidly digestible starch and C*Gel 04 201 contained predominantly slowly digestible starch. Each test starch, naturally enriched with 13 C, was fed to ten healthy female volunteers as part of a moderate fat test meal (containing 75 g test starch and 21 g fat), in a double-blind randomized crossover design. The metabolic response to each starch was measured after an overnight fast, in an acute 6 h study, before and after 14 d of daily consumption of 75 g test starch. During each acute study, blood samples were taken at 15 min intervals for the first 2 h and at 30 min intervals for the remaining 4 h. Breath 13 CO 2 enrichment was measured at the same time points and indirect calorimetry was performed for 20 min every 40 min immediately before and throughout the study. Significantly more rapid, greater changes in postprandial plasma glucose, NEFA and serum insulin concentrations were observed after consumption of the rapidly digestible starch. Breath 13 CO 2 output over the first 3-4 h rose rapidly then began to decline following consumption of the rapidly digestible starch, but plateaued for the slowly digestible starch. The 14 d adaptation period did not affect any of the glycaemic or lipaemic variables but there was a reduction in postprandial plasminogen activator inhibitor-1 concentrations. These data confirm that starches characterized as predominantly rapidly digestible versus slowly digestible by the Englyst procedure provoke distinctly different patterns of metabolism postprandially.
The joint FAO/WHO (1998) committee recommended consumption of a diet containing at least 55 % of total energy from carbohydrates, to maintain health and prevent disease. Variation in the source of carbohydrate was also advised, in acknowledgement of the diverse metabolic responses to different food carbohydrates. One of the most important metabolic responses is the rate and extent of glucose absorption and subsequent insulin secretion. When a normal concentration of insulin in blood produces a less than normal biological response, the individual is termed 'insulin resistant' (Wallace & Matthews, 2002) . This sub-optimal state predisposes individuals to the complex metabolic abnormalities implicated in the aetiology of cancer (Argiles & LopezSoriano, 2001; Yoshikawa et al. 2001) , ageing (Facchini et al. 2000) , CVD and diabetes (Reaven, 1995) . As the amount, rate and extent of carbohydrate digestion are key determinants of postprandial glucose and insulin response (Wolever, 2000) , modulation of carbohydrate digestion patterns could provide many health benefits. However, predicting the glycaemic response to a carbohydrate has proved difficult. Unlike dietary fats, which are categorized in food composition tables to identify key characteristics, e.g. saturated and unsaturated, and family, e.g. n-6 and n-3, at best food tables provide data on total starch. Glycaemic predictions therefore rely upon a combination of in vitro procedures which classify starches according to their rate of hydrolysis (Englyst et al. 1992 (Englyst et al. , 1999 (Englyst et al. , 2000 Champ, 1999) , or in vivo measurements of glycaemic index (GI) (Jenkins et al. 1981 (Jenkins et al. , 2002 Bornet et al. 1989; Wolever, 2000) and studies using stable isotope-labelled carbohydrates (Normand et al. 1992; Vonk et al. 2000) .
Given the advances in understanding the roles of food starches in health, there is a need to categorize starches according to their rate and extent of small intestinal digestion. Consumption of slowly digestible starches could assist the prevention and management of insulin resistance and diabetes, thus potentially alleviating the increasing burden of the associated non-communicable diseases. The aim of the present study was to investigate two commercially available contrasting waxy maize food starches, naturally enriched with 13 C, with differing rates of in vitro hydrolysis. The effects of each starch on postprandial glycaemia, insulinaemia, lipaemia and haemostasis were assessed in healthy pre-menopausal women. Potential adaptations to starch exposure were also investigated by making these measurements before and after 14 d of daily test starch consumption.
Experimental methods

Subjects
The experimental protocol for the present study was approved by the joint ethics committees of Newcastle and North Tyneside Health Authorities. Each subject gave their informed, written consent to participate. All studies were conducted in the Wellcome Research Laboratories, University of Newcastle, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Ten healthy pre-menopausal women, aged 20 -37 years, were recruited from the student and staff population of the University of Newcastle upon Tyne. All volunteers had a BMI between 20 and 29 kg/m 2 and were not pregnant, lactating, a smoker, or taking medication known to alter insulin sensitivity, carbohydrate or lipid metabolism, and were not following a diet for medical reasons. Fasting blood cholesterol, glucose and insulin concentrations were within the normal range for each participating volunteer.
The experimental starches and test meal
The experimental starches were C*Set 06598, a rapidly digestible pregelatinized thinned waxy maize starch (coded starch A) and C*Gel 04201, a slowly digestible native waxy maize starch (coded starch B) and were provided by Cerestar (Vilvoorde, Belgium). The starches were selected following in vitro digestion of a range of commercially available food starches, using the protocol described by Englyst et al. (2000) , to identify starches with contrasting contents of slowly and rapidly digestible starch. The test starches were supplied pre-weighed, packaged and coded by Cerestar, to ensure 'blinding' of the research team. 'Milkshake' test meals containing 75 g of either test starch (allocated to each volunteer using a random numbers table), 250 g skimmed milk, 40 g double cream, 7 g cocoa powder, 2·6 g artificial sweetener (Tesco own brand) and 100 g chilled water were prepared immediately before consumption by the volunteers. This provided a palatable starch meal with a moderate fat content of 21 g known to represent a standard meal, without flattening the postprandial glycaemic response (based on work by Normand et al. 2001) .
The experimental protocol
Each volunteer participated in two experimental periods, in a randomized, double-blind, crossover design. During each experimental period, volunteers attended two acute studies. The first study examined the effect of test starch consumption against a background of the subjects' habitual diet. The second, identical acute study was carried out at the end of a 14 d 'adaptation' period, during which the volunteers were asked to replace regularly consumed dietary starch with 75 g of the test starch on a daily basis. All volunteers received advice and guidance on the most appropriate methods of incorporating the test starches into their diets. The first experimental period was followed by a 2-week 'washout' period, before the second experimental period with the second test starch was carried out. This allowed 1 month to elapse between the beginning of the first and second experimental periods, thus allowing the investigation of responses to each starch to occur as close as possible to a fixed point in the volunteers' menstrual cycles. The experimental protocol is summarized in Fig. 1 .
For the 24 h prior to each acute study day, each volunteer was advised to avoid alcohol, strenuous exercise and 13 C-containing foods. A standard 13 C-free evening meal was provided and consumed before 21.00 hours after which the volunteers fasted overnight. This meal consisted of 'Three cheese and broccoli bake' (450 g), baked potato (180 g), lettuce (150 g), strawberries (100 g) and grapes (100 g). For each acute study day, subjects were admitted at 08.00 hours and an intravenous cannula was inserted into the antecubital vein for collection of baseline fasting and postprandial blood samples. The test meal was consumed within 10 min and postprandial blood and breath samples were collected every 15 min for the first 2 h and every 30 min for the remaining 4 h. Indirect calorimetry measurements were made using a Deltatrac Indirect Calorimeter (Datex Instrumentarium Corporation, Helsinki, Finland) for 20 min at 40 min intervals, from 20 min before consumption of the test meal to the end of the study. Throughout the study the volunteers rested in bed and were allowed unlimited access to drinking water.
Habitual and test starch dietary intake of subjects and anthropometric measurements
The volunteers' food intake was estimated from 7 d food records collected before the study commenced, to assess baseline (habitual) food intake, and during each period of test starch 'adaptation', to Fig. 1 . Experimental protocol summary. I In the 24 h prior to each study, strenuous activity, alcohol consumption and 13 C-rich foods were avoided; the evening prior to each study the standardized meal was consumed and each volunteer was asked to fast from 9.00 hours (still water available ad libitum). PABA, p-aminobenzoic acid; WHR, waist:hip ratio.
determine to what extent the habitual diet was altered by the supplemental test starch. Food portion sizes were quantified using the aid of a photographic atlas (Nelson et al. 1997 ) and face-to-face interviews with the subjects upon completion of the record. Nutrient intakes were calculated from food records using WinDiets Nutritional Analysis Software Suite (Robert Gordon University, Aberdeen). The food records were validated by comparing estimated food N intake with 24 h urinary N excretion. Completeness of the urine collection was assessed through recovery of a 240 mg oral dose of p-amino-benzoic acid in urine Cummings, 1983, 1985) . Weight, height and waist -hip circumference measurements were taken at the start of each acute study day for each volunteer.
Analytical methods
Plasma glucose, NEFA and serum insulin concentrations were determined using standard enzymic procedures as described previously (Daly et al. , 2000 . The fasting and 6 h postprandial blood haemostasis markers were assayed as follows: (1) plasma plasminogen activator inhibitor-1 (PAI-1) was analysed using an ELISA kit from Technoclone (Dorking, surrey; Art.-Nr.12 075); (2) plasma fibrinogen analysis was carried out on an automated coagulation analyzer (COAG-A-MATE MTX II; Biomerieux, Durham NC, USA) using MDA Fibriquick (Biomerieux). Whole blood cholesterol was determined using an enzymatic hydrolysis and oxidation performed on an Olympus automated chemistry analyser (Middlesex, UK; model AU640). Enrichment of 13 CO 2 in breath and enrichment of 13 C in the test starches were determined by isotope ratio MS using an ANCA 20:20 mass spectrometer (Europa Scientific, Crewe, UK).
Calculations and statistical analyses
Area under the curve (AUC) and area over the curve (AOC) were calculated using the standard trapezoid procedure. The rate of excretion of 13 C as 13 CO 2 in breath was calculated as the product of 13 CO 2 enrichment (percentage of atoms above background) and CO 2 production (determined by indirect calorimetry at each time-point during the experimental period) as described previously (Daly et al. 2000; Seal et al. 2003) . The cumulative output of 13 C over the 360 min experimental period was calculated from the incremental AUC for 13 CO 2 output and expressed as a percentage of the original 13 C dose above background for each individual.
All data were analysed statistically using the ANOVA general linear model and MINITAB (Coventry, UK) release 13. Of the ten volunteers recruited, all ten successfully completed both study days for starch B, but due to cannulation problems, one of the volunteers was unable to complete the studies for starch A.
Results
In vitro starch hydrolysis
The release of glucose following hydrolysis by the Englyst et al. (2000) , method of starch classification for the two test starches, is illustrated in Fig. 2 . Starch A contained 95·5 % rapidly digestible starch and 0·0 % slowly digestible starch, compared with starch B, which contained only 46·8 % rapidly digestible starch and 45·5 % slowly digestible starch. As a result starch A was rapidly hydrolysed, with glucose release reaching a plateau quickly after just 10 min, compared with starch B, which was slowly hydrolysed, reaching a plateau after 70 min. The resistant starch content for both starches was low, at 5·2 % for starch A and 7·7 % for starch B.
Subject characterization
Each volunteer recruited was young, relatively lean and healthy (Table 1) . Habitual daily energy and nutrient intakes (Table 2) show that, on average, 30 % of dietary energy was derived from fat, which more than meets the Department of Health (1991) recommendations. In addition, carbohydrates provided on average approximately 50 % of dietary energy. Whilst these values differed significantly (P,0·05) between individual volunteers, no variation occurred between the three periods of dietary recording. Starch intake as a percentage of total energy was significantly higher during both 14 d periods of test starch consumption, when compared with baseline. Starch intake as a percentage of total carbohydrate was greater during the 14 d periods of test starch consumption, but this was significant only for test starch B.
Nutrient intake data were verified by the comparison of urinary N output with N intakes from analysis of the food diaries, which showed a mean ratio of 0·84 across all three periods. The completeness of the 24 h urine collections were verified by p-amino-benzoic acid recoveries which averaged 98·9 % (Table 2) .
Test starch adaptation period (14 d)
With the exception of the postprandial PAI-1 concentrations (discussed later), there were no significant (P, 0·05) effects following the 14 d consumption of either test starch.
Glucose and insulin concentrations
Fasting glucose and insulin concentrations, averaged across the four study days, were 4·97 (pooled SEM 0·09) mmol/l and 5·1 (pooled SEM 0·11) mu/l, respectively. There were marked differences in the postprandial plasma glucose and serum insulin profiles, between test starches (Figs 3 and 4; Table 3 ). Following consumption of the rapidly digestible starch A, concentrations of both glucose and insulin rose more rapidly and to higher peaks than after consumption of The digestion conditions were those described by Englyst et al. (2000) .
the slowly digestible starch B. The AUC insulin to glucose ratios demonstrated that during the first 120 min of each acute study, starch A evoked a significantly higher insulin response, when compared with the insulin response required for the same quantity of plasma glucose with starch B.
13 C metabolism. Breath 13 CO 2 output ( Fig. 5 ) was determined as a measure of glucose absorption and oxidation following consumption of the test starches which were naturally enriched with 13 C. 13 CO 2 output was consistently higher following consumption of starch A during the first 240 min, after which output began to decline, in contrast with starch B where 13 CO 2 output rose to a plateau at 270 min and remained stable until the end of the study at 360 min. The peak 13 CO 2 output values achieved for each starch were also significantly different (P¼0·004) ( Table 4) , with starch A reaching a peak of 0·0139 mg 13 C/min (averaged across both study days), compared with starch B which reached a peak of just 0·0105 mg 13 C/min (average across both study days). Analysis of 13 C recovery showed that significantly more labelled carbon was recovered as 13 CO 2 following consumption of starch A, when compared with starch B, after both 120 and 360 min of the study (P¼0·003 and P¼0·016, respectively).
Plasma NEFA and cholesterol
After the initial 15 min, plasma NEFA concentrations (Fig. 6 ) fell rapidly after consumption of both test starches. Although lower troughs were reached after consumption of starch A, compared with starch B, the net changes from baseline were not statistically significant. NEFA concentrations remained well below fasting values until 180 min after the test meals, for both starches, before rising slowly to baseline concentrations for starch B, and rising rapidly to well above fasting concentrations for starch A. These patterns of change were also reflected in the highly significant (P,0.001) differences in time spent below fasting concentrations and AOC between T0 and T120 (Table 5) .
Fasting (T0) and end of study (T360) serum cholesterol data are shown in Table 6 . Neither test starch had a significant effect on total cholesterol concentrations at either time-point. In addition, HDL:LDL ratio was also unaffected by the treatments.
Haemostasis factors
Plasma concentrations of fibrinogen and PAI-1 were analysed before (T0) and at the end (T360) of each acute study (Table 6 ). Fibrinogen concentrations were not affected by the consumption of either test starch and remained within a physiologically normal range throughout each acute study. For PAI-1, whilst there was no significant difference in circulating concentrations following consumption of either test starches, the 14 d period of exposure to the test starches reduced significantly postprandial PAI-1 concentrations (Table 6 ). In the initial acute studies, the T360 PAI-1 values were more than double baseline values for both starches A and B. However, after 14 d consumption of either test starch, whilst there was no difference in the baseline fasting (T0) values, the increase in PAI-1 concentrations at T360 were significantly blunted (by approximately 70 %) for each treatment.
Discussion
The results of epidemiological and experimental studies suggest that the rate and extent of dietary starch digestion can affect a range of physiological indices and modulate the risk of several common non-communicable diseases, in particular those related to insulin resistance (FAO/WHO, 1998; , 2001 . In the present study two starches with contrasting digestion patterns were used to assess (1) whether the Englyst et al. (2000) method of classifying rapidly and slowly digestible starches reflects glycaemic responses in vivo; (2) differences in glycaemic, insulinaemic, lipaemic and haemostasic responses to a test meal; and (3) whether the metabolic consequences of starch consumption are modulated after a 14 d period of exposure to the test starches. To date, probably the most widely utilized method of predicting glycaemic responses to starchy foods is the GI, and a list of GI for a range of different foods was compiled by Foster-Powell & BrandMiller (1995) . However, this methodology requires the use of human volunteers and concerns have been raised over the applicability of the GI approach to complex meals (Flint et al. 2004 ) and different population groups. The usefulness of in vitro approaches to predict in vivo glycaemia remains unclear. Holm & Bjorck (1992) have described procedures for characterizing starch digestion in vtiro and made comparisons with in vivo metabolic responses whilst Englyst et al. (1992 Englyst et al. ( , 2000 provide an in vitro method for quantifying the rapidly digestible, slowly digestible and resistant starch fractions of starchy foods. Englyst et al. (1999) also suggested that rapidly available glucose, determined from the hydrolysis protocol, provides a good indicator of glycaemic response in vivo.
The results from the present study demonstrate that the in vitro data are able to predict the glycaemic response to each test starch in the healthy female volunteers investigated. This is illustrated by a comparison of 120 min AUC ratios for starch A -starch B for glucose released following in vitro hydrolysis (1·17:1), with that for the plasma glucose response over the same time period (1·14:1).
As reported in a previous study from our group (Seal et al. 2003) , starches with different rates of digestion in vitro evoke significantly different glycaemic and insulinaemic responses. This is further confirmed in the present study with the rapidly digestible starch A, resulting in more pronounced rises and falls in plasma glucose and in serum insulin concentrations, compared with the slower, more sustained responses to the slowly digestible starch B. The differences between the two test starches during the first 120 min were, however, more exaggerated for the plasma glucose response, when compared with the insulin response. This enhanced insulin response was not reported in the Seal et al. (2003) study, however the test meals in that study contained no fat. It is possible that the insulin results reported here may have been affected by the co-ingestion of fat, which has been shown to stimulate early insulin secretion (Collier et al. 1984 (Collier et al. , 1988 . 13 CO 2 output in breath was used as an index of postprandial starch hydrolysis and subsequent glucose absorption and oxidation, although absorbed glucose which is not stored and not oxidized within the time-frame of the study is not measured by this approach. This analysis was possible as both test starches derive from naturally enriched maize (corn), which accumulates excess 13 C during CO 2 fixation in the C4 photosynthetic pathway (Taiz & Zieger, 1991) . In agreement with the postprandial glycaemia data, the rate of 13 CO 2 output and 13 C recovery for starch A were significantly higher than for starch B. The present data are in accord with the observations of Normand et al. (1992) and Seal et al. (2003) , in showing that glucose absorption and oxidation continued long after blood glucose concentrations had fallen back to fasting concentrations (for starch A) and approaching fasting concentrations for starch B. It has been suggested that the observed pattern of 13 CO 2 output is closely related to the pattern of glucose uptake from the gut, after the initial delay resulting from the postprandial surge of insulin, and the switch in overall metabolic oxidation from fat to glucose (Seal et al. 2003) . The data from the present study, along with others (Achour et al. 1997; Daly et al. 2000; Vonk et al. 2000; Seal et al. 2003) , demonstrate the utility of this 13 C-based approach in investigating the metabolic effects of starches with differing digestion patterns.
In accordance with findings from previous reports (Frayn, 1998; Normand et al. 2001; Seal et al. 2003) , the postprandial changes in NEFA concentrations from the present study correlated inversely with the insulin responses to each test starch. The resulting slower, more sustained level of circulating NEFA in response to the slowly digestible starch B, without the rapid rise in NEFA seen towards the end of the postprandial period following consumption of the rapidly digested starch A, could prove beneficial in lowering circulating NEFA concentrations.
It is documented that insulin resistance and the resulting elevation in NEFA can alter cholesterol concentrations by increasing production of triacylglycerol-enriched VLDL particles and reducing lipoprotein lipase activity (Abate, 2000) . Based on previous studies (Itoh et al. 1999; Jarvi et al. 1999) , it was hypothesized that the slowly digestible starch B would reduce cholesterol concentrations when compared with the rapidly digestible starch A. However, the results from the present study show that there were no differences between two test starches in either total cholesterol concentrations or HDL:LDL ratio, both during acute starch administration and following 14 d adaptation to the test starches. The present finding may suggest that the young, relatively lean female participants had good insulin sensitivity.
Raised concentrations of fibrinogen and PAI-1 have been linked mechanistically with insulinaemia and CHD development (Bastard et al. 2000; Raynaud et al. 2000; Kohler, 2002) . Although Rauramaa et al. (1994) demonstrated a strong inverse correlation between starch intake and fibrinogen levels in older men, neither test starch altered fibrinogen concentrations in the healthy female volunteers that participated in the present study. This result is perhaps unsurprising, since Raynaud et al. (2000) reported a highly significant correlation between fibrinogen and insulin sensitivity, and the volunteers in the present study may have been relatively insulin-sensitive. Further investigation in insulin-resistant and/or diabetic individuals is warranted.
When PAI-1 concentrations are raised, fibrinolytic activity is depressed and there is a subsequent increase in the risk of thrombosis. In the present study, PAI-1 concentrations in the initial acute study for both test starches more than doubled over the postprandial period, when compared with baseline concentrations. Carroll & Schade (2003) also reported a postprandial rise in PAI-1, which tripled from baseline concentrations to 4 h after a high-fat (70 g) meal served to type 2 diabetic participants. The higher fat content of the Carroll study meal may explain the more pronounced rise in postprandial PAI-1 concentrations. However, this theory is contradicted by Sanders et al. (2004) , who reported a postprandial decrease in PAI-1 concentrations, irrespective of the fat content of the test meal consumed by the non-diabetic, male participants. One possible explanation of these contrasting findings is physical activity levels, which are known to correlate inversely with PAI-1 concentrations (Rankinen et al. 1995; Ivey et al. 2003) . The participants of both the present and the Carroll study were rested in hospital throughout the postprandial sampling period, whilst the participants in the study by Sanders et al. (2004) were permitted to return to home or work between sampling. It is therefore likely that the activity levels were higher in the Sanders study, which may have reduced the postprandial PAI-1 concentrations.
A novel observation, previously unreported, is the significant blunting of the observed postprandial rise in PAI-1 concentrations after 14 d of regular test starch consumption, irrespective of the test starch consumed. The design of the present study makes it impossible to determine whether it was increased starch consumption and/or the compensatory decrease in other dietary carbohydrates per se which reduced postprandial PAI-1 concentrations, and the observation warrants further investigation.
During the present study, each metabolic parameter was examined before and after a 14 d period of daily test starch consumption, to establish whether habituation to the test starch influenced the metabolic outcomes. However, PAI-1 concentration was the only variable influenced by the regular test starch consumption. Since intestinal and pancreatic enzyme activities are known to respond to changes in dietary composition, it was hypothesized that metabolic 'adaptation' may result in a significant difference in the subsequent glycaemic and insulinaemic responses to each of the test starches. Previous studies have indeed suggested that increased starch intake over time stimulates specific amylase activity (Corring, 1980; Flores et al. 1988) and increases the rate of intestinal glucose transport (Ferraris et al. 2001) . The results from the present study, however, suggest that after the daily consumption of 75 g of either test starch over 14 d, neither fasting nor postprandial glycaemia, insulinaemia, NEFA, cholesterol or fibrinogen were altered significantly.
In conclusion, the results from the present study show that starches with contrasting hydrolysis characteristics in vitro have correspondingly different postprandial glycaemic and insulinaemic responses in healthy young female volunteers. The present findings suggest that consumption of slowly digestible starches could improve glycaemic control and lower postprandial NEFA concentrations, which could contribute to prevention and treatment of diabetes and complications of the metabolic syndrome. An increase in starch consumption per se may also reduce postprandial PAI-1 concentrations, thus reducing a potential risk factor implicated in the metabolic syndrome. 
